Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Повний опис

Бібліографічні деталі
Автори: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Формат: Стаття
Мова:English
Опубліковано: Taylor & Francis Group 2019-06-01
Серія:CNS Oncology
Предмети:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Онлайн доступ:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Схожі ресурси

Схожі ресурси